Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Advanced GIST After Imatinib and Sunitinib Failure
NCT01091207Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in gastrointestinal stromal tumor (GIST), sponsored by Samsung Medical Center. Started Nov 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01091207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091207.